Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지

Methacholine and adenosine 5'-monophosphate challenge tests in children with atopic asthma and with nonatopic asthma, and their relationships to blood eosinophil markers.

아토피성 천식 환아와 비아토피성 천식 환아에서 메타콜린과 아데노신 기관지 유발 검사의 비교 및 혈중 호산구 염증 지표와의 관련성

  • Lee, Sun Hee (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Kim, Do Kyun (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Choi, Sun Hee (Department of Pediatrics, College of Medicine, Seoul National University) ;
  • Koh, Young Yull (Department of Pediatrics, College of Medicine, Seoul National University)
  • 이선희 (서울대학교 의과대학 소아과학교실) ;
  • 김도균 (서울대학교 의과대학 소아과학교실) ;
  • 최선희 (서울대학교 의과대학 소아과학교실) ;
  • 고영률 (서울대학교 의과대학 소아과학교실)
  • Received : 2006.08.23
  • Accepted : 2006.09.13
  • Published : 2006.11.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : Though atopic and nonatopic asthma have different clinical manifestations, bronchial hyperresponsiveness (BHR) and airway inflammations are common characteristics of them. We investigated BHR to both methacholine and adenosine 5'-monophosphate (AMP), and their relationships with blood eosinophil markers in nonatopic asthma as well as atopic asthma. Methods : We studied 116 children (82 atopics; 34 nonatopics) with mild to moderate asthma. Methacholine and AMP challenge tests were performed and bronchial responsiveness was expressed as $PC_{20}$ (provocative concentration causing a 20 percent fall in $FEV_1$); blood eosinopil counts (ETCs) and serum eosinophil cationic protein (ECP) levels were gauged. Results : In atopics, 95.1 percent and 90.2 percent showed hyperreactivity to methacholine ($PC_{20}$<16 mg/mL) and AMP ($PC_{20}$<200 mg/mL), respectively. Meanwhile, in nonatopics, 94.1 percent and 52.9 percent displayed hyperreactivity to methacholine and AMP, respectively. The geometric mean of AMP $PC_{20}$ was lower in atopics (31.6 mg/mL) than in nonatopics (125.9 mg/mL); that of methacholine $PC_{20}$ was similar in the two groups. AMP $PC_{20}$ correlated with blood ETCs in both atopics(r=-0.30, P<0.01) and nonatopics (r=-0.57, P<0.01), and correlated with serum ECP levels (r=-0.23, P<0.01) in atopics, but not in nonatopics. Apart from AMP, methacholine $PC_{20}$ was not associated with blood eosinophil markers in either group. Conclusion : Atopics more frequently displayed BHR to AMP than nonatopics. Furthermore, BHR to AMP was associated with not only blood ETCs, but serum ECP levels in atopics but was correlated with only blood ETCs in nonatopics. Those results suggest that BHR to AMP reflects airway inflammation in asthma and is more related to atopy.

목 적 : 아토피성 천식과 비아토피성 천식은 서로 다른 임상양상을 나타내지만 기도 과민성과 기도 염증은 이들 천식의 특징적 소견이다. 본 연구에서는 아토피성 천식과 비아토피성 천식에서 직접 기관지 유발 검사인 메타콜린에 대한 반응과 간접 기관지 유발 검사인 아데노신에 대한 반응의 차이가 있는지, 그리고 이들 기관지 유발 검사와 혈중 호산구 염증 지표들의 연관성에 대해 알아보고자 하였다. 방 법 : 본 연구는 경증 천식 및 중등도 천식으로 진단받은 환아 116명을 대상으로 하였으며 이중 아토피성 천식군이 82명, 비아토피성 천식군이 34명이었다. 환아들은 혈중 호산구 수와혈청 eosinophil cationic protein(ECP) 농도를 측정하였고 메타콜린과 아데노신 기관지 유발 검사를 시행하였다. 기관지 유발검사에 대한 반응은 메타콜린 $PC_{20}$와 아데노신 $PC_{20}$로 나타내었고 기도 과민성의 판정 기준은 각각 메타콜린 $PC_{20}$이 16 mg/mL 미만인 경우와 아데노신 $PC_{20}$이 200 mg/mL 미만인 경우로 하였다. 결 과 : 아토피성 천식군에서 각각 95.1%와 90.2%가 메타콜린 기관지 유발 검사와 아데노신 기관지 유발 검사에 양성을 보였고 비아토피성 천식군에서는 각각 94.1%와 52.9%가 메타콜린과 아데노신 기관지 유발 검사에 양성을 나타내었다. 아토피성 천식군과 비아토피성 천식군에서 아데노신 $PC_{20}$의 기하평균은 31.6 mg/mL과 125.6 mg/mL로 아토피성 천식군에서 더 낮은 값을 보였고 메타콜린 $PC_{20}$의 기하평균은 차이가 없었다. 기도과민성과 혈중 호산구 염증 지표들과의 관련성은 아데노신 기도과민성의 경우 아토피성 천식군에서는 혈청 ECP 농도와 r=-0.23, P<0.01, 혈중 호산구 수와는 r=-0.30, P<0.01로 연관성이 있었고 비아토피성 천식군에서는 혈청 ECP 농도와는 연관성이 없었으나 혈중 호산구 수와는 r=-0.57, P<0.01로 유의한 상관관계를 보였다. 그러나 메타콜린 기도 과민성의 경우 두 군 모두에서 혈중 호산구 염증 지표들과 연관성이 없었다. 결 론 : 아토피성 천식 환아들은 비아토피성 천식 환아들에 비해 더 심한 아데노신 기도 과민성을 보였다. 또한, 아토피성 천식 환아들에서 아데노신 기도 과민성은 혈중 호산구 수 뿐만 아니라 혈청 ECP 농도와도 연관성을 보였다. 그러나 비아토피성 천식 환아들은 혈중 호산구 수와만 상관관계를 보였다. 따라서 아데노신 기도 과민성은 천식의 기도 염증을 반영하나 비아토피성 천식의 기도 염증보다는 아토피성 천식에서의 기도 염증을 더 잘 반영하는 것으로 생각된다.

Keywords

References

  1. Lemanske RF Jr, Busse WW. 6. Asthma. J Allergy Clin Immunol 2003;111(2 Suppl):502S-19S https://doi.org/10.1067/mai.2003.94
  2. Sun YH, Koh YY. Bronchial hyperresponsiveness. Pediatr Allergy Respir Dis(Korea) 2000;10:89-103
  3. Polosa R, Holgate ST. Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma- Thorax 1997;52:919-23 https://doi.org/10.1136/thx.52.10.919
  4. Cockcroft DW. How best to measure airway responsiveness. Am J Respir Crit Care Med 2001;163:1514-5 https://doi.org/10.1164/ajrccm.163.7.2103055b
  5. van Schoor J, Pauwels R, Joos G. Indirect bronchial hyperresponsiveness: the coming of age of a specific group of bronchial challenges. Clin Exp Allergy 2005;35:250-61 https://doi.org/10.1111/j.1365-2222.2005.02177.x
  6. Frigas E, Gleich GJ. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol 1986;77:527-37 https://doi.org/10.1016/0091-6749(86)90341-6
  7. Adelroth E, Rosenhall L, Johansson SA, Linden M, Venge P. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline. Am Rev Respir Dis 1990;142:91-9 https://doi.org/10.1164/ajrccm/142.1.91
  8. Niimi A, Amitani R, Suzuki K, Tanaka E, Murayama T, Kuze F. Serum eosinophil cationic protein as a marker of eosinophilic inflammation in asthma. Clin Exp Allergy 1998;28:233-40 https://doi.org/10.1046/j.1365-2222.1998.00217.x
  9. Claman DM, Boushey HA, Liu J, Wong H, Fahy JV. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol 1994;94:861-9 https://doi.org/10.1016/0091-6749(94)90154-6
  10. Riise GC, Andersson B, Ahlstedt S, Enander I, Soderberg M, Lowhagen O, et al. Bronchial brush biopsies for studies of epithelial inflammation in stable asthma and nonobstructive chronic bronchitis. Eur Respir J 1996;9:1665-71 https://doi.org/10.1183/09031936.96.09081665
  11. Corrigan C. Mechanisms of intrinsic asthma. Curr Opin Allergy Clin Immunol 2004;4:53-6 https://doi.org/10.1097/00130832-200402000-00011
  12. Ludviksdottir D, Janson C, Bjornsson E, Stalenheim G, Boman G, Hedenstrom H, et al. Different airway responsiveness profiles in atopic asthma, nonatopic asthma, and Sjogren's syndrome. BHR Study Group. Bronchial hyperresponsiveness. Allergy 2000;55:259-65 https://doi.org/10.1034/j.1398-9995.2000.00252.x
  13. Phillips GD, Holgate ST. Absence of a late-phase response or increase in histamine responsiveness after bronchial provocation with adenosine 5'-monophosphate in atopic and non-atopic asthma. Clin Sci (Lond) 1988;75:429-36 https://doi.org/10.1042/cs0750429
  14. van Velzen E, van den Bos JW, Benckhuijsen JA, van Essel T, de Bruijn R, Aalbers R. Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax 1996;51:582-4 https://doi.org/10.1136/thx.51.6.582
  15. Oosterhoff Y, Koeter GH, De Monchy JG, Postma DS. Circadian variation in airway responsiveness to methacholine, propranolol, and AMP in atopic asthmatic subjects. Am Rev Respir Dis 1993;147:512-7 https://doi.org/10.1164/ajrccm/147.3.512
  16. Kim DK, Choi SH, Yu JH, Yoo Y, Koh YY. Methacholine and adenosine 5'-monophosphate challenge tests in children with asthma: relationship to eosinophil markers in blood. J Asthma Allergy Clin Immunol(Korea) 2006;26:52-8
  17. van Den Berge M, Meijer RJ, Kerstjens HA, de Reus DM, Koeter GH, Kauffman HF, et al.$ PC_{20}$ adenosine 5'-monophosphate is more closely associated with airway inflammation in asthma than$ PC_{20}$ methacholine. Am J Respir Crit Care Med 2001;163:1546-50 https://doi.org/10.1164/ajrccm.163.7.2010145
  18. American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995;152:1107-36 https://doi.org/10.1164/ajrccm.152.3.7663792
  19. Chai H, Farr RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, et al. Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975;56:323-7 https://doi.org/10.1016/0091-6749(75)90107-4
  20. Joos GF, O'Connor B, Anderson SD, Chung F, Cockcroft DW, Dahlen B, et al. Indirect airway challenges. Eur Respir J 2003;21:1050-68 https://doi.org/10.1183/09031936.03.00008403
  21. Venge P. Serum measurements of eosinophil cationic protein(ECP) in bronchial asthma. Clin Exp Allergy 1993;23(2 Suppl):3S-7S
  22. Peachell PT, Columbo M, Kagey-Sobotka A, Lichtenstein LM, Marone G. Adenosine potentiates mediator release from human lung mast cells. Am Rev Respir Dis 1988;138:1143-51 https://doi.org/10.1164/ajrccm/138.5.1143
  23. Polosa R, Pagano C, Prosperini G, Low JL, Dokic D, Church MK, et al. Histamine release upon adenosine 5'-monophosphate( AMP) nasal provocation in allergic subjects. Thorax 1999;54:230-233 https://doi.org/10.1136/thx.54.3.230
  24. Alvarez MJ, Olaguibel JM, Garcia BE, Rodriquez A, Tabar AI, Urbiola E. Airway inflammation in asthma and perennial allergic rhinitis. Relationship with nonspecific bronchial responsiveness and maximal airway narrowing. Allergy 2000;55:355-62 https://doi.org/10.1034/j.1398-9995.2000.00312.x
  25. Crimi E, Spanevello A, Neri M, Ind PW, Rossi GA, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998;157:4-9 https://doi.org/10.1164/ajrccm.157.1.9703002
  26. Gruber W, Eber E, Pfleger A, Modl M, Meister I, Weinhandl E, et al. Serum eosinophil cationic protein and bronchial responsiveness in pediatric and adolescent asthma patients. Chest 1999;116:301-5 https://doi.org/10.1378/chest.116.2.301
  27. Piacentini GL, Bodini A, Costella S, Suzuki Y, Zerman L, Peterson CG, et al. Exhaled nitric oxide, serum ECP and airway responsiveness in mild asthmatic children. Eur Respir J 2000;15:839-43 https://doi.org/10.1034/j.1399-3003.2000.15e05.x
  28. De Meer G, Heederik D, Postma DS. Bronchial responsiveness to adenosine 5'-monophosphate(AMP) and methacholine differ in their relationship with airway allergy and baseline FEV1. Am J Respir Crit Care Med 2002;165:327-31 https://doi.org/10.1164/ajrccm.165.3.2104066
  29. Gibson PG, Saltos N, Borgas T. Airway mast cells and eosinophils correlate with clinical severity and airway hyperresponsiveness in corticosteroid-treated asthma. J Allergy Clin Immunol 2000;105:752-9 https://doi.org/10.1067/mai.2000.105319
  30. Niimi A, Matsumoto H. Serum measurement of eosinophil cationic protein in the management of asthma. Curr Opin Pulm Med 1999;5:111-7 https://doi.org/10.1097/00063198-199903000-00006